Access to essential anticancer medicines for children and adolescents

Cancer medicines on the WHO model list of essential medicines: processes, challenges, and a way forward

Xevinapant plus standard of care chemoradiotherapy improved 5 year OS for unresected LA SCCHN

Value based care with a focus on education

Choosing the control arm/standard of care in clinical trials

Choosing Wisely and the National Cancer grid efforts in reducing low value cancer care in India

Building collaborations for cancer research

Defining Value in Indian healthcare: Asking the right questions

Sustainability in delivering healthcare - The Gordon McVie Lecture

ESMO 2022: Breast and ovarian trial analysis

ERMES study suggests a strategy of de-escalation with only cetuximab in first line therapy for RAS and BRAF wild type mCRC

Neoadjuvant immunotherapy improves outlook in high-risk melanoma